View in EDS HTML Full Text PDF Full Text

Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.
Authors: Mushtaq MU; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Harrington AM; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA., Chaudhary SG; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Michaelis LC; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Carlson KB; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Abedin S; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Runass L; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Callander NS; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Fallon MJ; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Juckett M; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Hall AC; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Hematti P; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Mattison RJ; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Atallah EL; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Guru Murthy GS; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2021 Jan; Vol. 62 (1), pp. 158-166. Date of Electronic Publication: 2020 Sep 19.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32951486
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mushtaq+MU%22">Mushtaq MU</searchLink>; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Harrington+AM%22">Harrington AM</searchLink>; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Chaudhary+SG%22">Chaudhary SG</searchLink>; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Michaelis+LC%22">Michaelis LC</searchLink>; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Carlson+KB%22">Carlson KB</searchLink>; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Abedin+S%22">Abedin S</searchLink>; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Runass+L%22">Runass L</searchLink>; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Callander+NS%22">Callander NS</searchLink>; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Fallon+MJ%22">Fallon MJ</searchLink>; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Juckett+M%22">Juckett M</searchLink>; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Hall+AC%22">Hall AC</searchLink>; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Hematti+P%22">Hematti P</searchLink>; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Mattison+RJ%22">Mattison RJ</searchLink>; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Atallah+EL%22">Atallah EL</searchLink>; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Guru+Murthy+GS%22">Guru Murthy GS</searchLink>; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2021 Jan; Vol. 62 (1), pp. 158-166. <i>Date of Electronic Publication: </i>2020 Sep 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32951486
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2020.1821009
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 158
    Titles:
      – TitleFull: Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mushtaq MU
      – PersonEntity:
          Name:
            NameFull: Harrington AM
      – PersonEntity:
          Name:
            NameFull: Chaudhary SG
      – PersonEntity:
          Name:
            NameFull: Michaelis LC
      – PersonEntity:
          Name:
            NameFull: Carlson KB
      – PersonEntity:
          Name:
            NameFull: Abedin S
      – PersonEntity:
          Name:
            NameFull: Runass L
      – PersonEntity:
          Name:
            NameFull: Callander NS
      – PersonEntity:
          Name:
            NameFull: Fallon MJ
      – PersonEntity:
          Name:
            NameFull: Juckett M
      – PersonEntity:
          Name:
            NameFull: Hall AC
      – PersonEntity:
          Name:
            NameFull: Hematti P
      – PersonEntity:
          Name:
            NameFull: Mattison RJ
      – PersonEntity:
          Name:
            NameFull: Atallah EL
      – PersonEntity:
          Name:
            NameFull: Guru Murthy GS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2021 Jan
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 62
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1